Bacterial cell wall and membrane biosynthesis proteins

Bacterial cell wall and membrane biosynthesis proteins represent a broad class of essential enzymes and structural components required for the assembly and maintenance of the bacterial envelope. This group includes Penicillin-Binding Proteins (PBPs), which facilitate peptidoglycan cross-linking, and the Mur family of enzymes responsible for synthesizing peptidoglycan precursors (Silver, 2011, Clinical Microbiology Reviews). These proteins are vital for protecting the bacterium from osmotic lysis and providing structural rigidity. Because many of these biosynthetic pathways are absent in eukaryotic cells, they are primary targets for many of the most successful classes of antibiotics, including beta-lactams, glycopeptides, and phosphonic acids (Bush & Bradford, 2016, Cold Spring Harbor Perspectives in Medicine). Drugs targeting these proteins typically act by inhibiting specific enzymatic steps, leading to a weakened cell wall and subsequent cell death. However, the clinical utility of these targets is constantly challenged by the emergence of resistance mechanisms, such as target site mutations or the production of degrading enzymes like beta-lactamases (Sauvage et al., 2008, FEMS Microbiology Reviews). Additionally, some agents like polymyxins target the bacterial membrane directly by interacting with lipopolysaccharides in Gram-negative bacteria (Velkov et al., 2013, Future Microbiology).

Other names

Bacterial envelope biosynthesis proteinsPeptidoglycan synthesis enzymesCell wall assembly proteins

Inhibition of peptidoglycan transpeptidation, inhibition of initial stages of peptidoglycan synthesis (e.g., MurA inhibition), disruption of bacterial membrane integrity, and inhibition of lipid carrier recycling (Sauvage et al., 2008; Silver, 2011).